Cover Image
市場調查報告書

Tocagen Inc.的產品平台分析

Tocagen Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321980
出版日期 內容資訊 英文 30 Pages
訂單完成後即時交付
價格
Back to Top
Tocagen Inc.的產品平台分析 Tocagen Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 30 Pages
簡介

Tocagen Inc.是總公司設立於美國的生物製藥企業,從事癌症治療藥的藥物研發·開發。商品化。正在開發設計對腫瘤之選擇性運作免疫系統活性化之非複製反轉錄病毒媒介等。

本報告提供Tocagen Inc. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Tocagen Inc. 的基本資料

  • Tocagen Inc. 概要
  • 主要資訊
  • 企業資料

Tocagen Inc. :R&D概要

  • 主要的治療範圍

Tocagen Inc. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Tocagen Inc. :開發中產品概況

  • 臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Tocagen Inc. :藥物簡介

  • vocimagene amiretrorepvec + flucytosine ER
  • Toca- RNAi
  • Toca-Gamma

Tocagen Inc. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Tocagen Inc. :最新的開發平台資訊

Tocagen Inc. :中止開發的產品

Tocagen Inc. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07545CDB

Summary

Global Markets Direct's, 'Tocagen Inc. - Product Pipeline Review - 2015', provides an overview of the Tocagen Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Tocagen Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Tocagen Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Tocagen Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Tocagen Inc.'s pipeline products

Reasons to buy

  • Evaluate Tocagen Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Tocagen Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Tocagen Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Tocagen Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tocagen Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Tocagen Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Tocagen Inc. Snapshot
    • Tocagen Inc. Overview
    • Key Information
    • Key Facts
  • Tocagen Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Tocagen Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Tocagen Inc. - Pipeline Products Glance
    • Tocagen Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Tocagen Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Tocagen Inc. - Drug Profiles
    • vocimagene amiretrorepvec + flucytosine ER
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Toca-421
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Toca-Gamma
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Toca-RNAi
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Tocagen Inc. - Pipeline Analysis
    • Tocagen Inc. - Pipeline Products by Target
    • Tocagen Inc. - Pipeline Products by Route of Administration
    • Tocagen Inc. - Pipeline Products by Molecule Type
    • Tocagen Inc. - Pipeline Products by Mechanism of Action
  • Tocagen Inc. - Recent Pipeline Updates
  • Tocagen Inc. - Dormant Projects
  • Tocagen Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Tocagen Inc., Key Information
  • Tocagen Inc., Key Facts
  • Tocagen Inc. - Pipeline by Indication, 2015
  • Tocagen Inc. - Pipeline by Stage of Development, 2015
  • Tocagen Inc. - Monotherapy Products in Pipeline, 2015
  • Tocagen Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Tocagen Inc. - Phase II, 2015
  • Tocagen Inc. - Phase I, 2015
  • Tocagen Inc. - Preclinical, 2015
  • Tocagen Inc. - Pipeline by Target, 2015
  • Tocagen Inc. - Pipeline by Route of Administration, 2015
  • Tocagen Inc. - Pipeline by Molecule Type, 2015
  • Tocagen Inc. - Pipeline Products by Mechanism of Action, 2015
  • Tocagen Inc. - Recent Pipeline Updates, 2015
  • Tocagen Inc. - Dormant Developmental Projects,2015

List of Figures

  • Tocagen Inc. - Pipeline by Top 10 Indication, 2015
  • Tocagen Inc. - Pipeline by Stage of Development, 2015
  • Tocagen Inc. - Combination Treatment Modalities in Pipeline, 2015
  • Tocagen Inc. - Pipeline by Top 10 Target, 2015
  • Tocagen Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Tocagen Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Tocagen Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top